Fiona is Director of Clinical Research for Duchenne UK. Fiona previously worked for 5 years for Prosensa, a Dutch company that was developing exon skipping therapies for Duchenne Muscular Dystrophy. Whilst at Prosensa Fiona led the clinical project team that was focused on skipping exon 44. In addition she has many years’ experience organizing clinical research in other therapeutic areas for Pharma/Biotech companies and not for profit/public sector organisations.
Fiona has been a member of the DUK Scientific Advisory Board for 2 years and is also currently head of clinical and regulatory affairs for a small pharma company focused on developing treatments for diabetes.
Fiona was instrumental in helping to bring the Tamoxifen trial to the UK and assist the Swiss team with regulatory advice.
Published on 21 August 2017Share this articleCategories Uncategorised